Pictet Asset Management Sa Halozyme Therapeutics, Inc. Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 15,982 shares of HALO stock, worth $862,388. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,982
Previous 219,804
92.73%
Holding current value
$862,388
Previous $8.39 Million
93.14%
% of portfolio
0.0%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding HALO
# of Institutions
536Shares Held
124MCall Options Held
177KPut Options Held
167K-
Black Rock Inc. New York, NY17.6MShares$951 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$696 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$358 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$219 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$184 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.52B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...